news.png
HOME > Media > News and press release
print.png
email.png

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data
 
Chiesi Launch Initiative to Support Academic Research in...
Chiesi Launch Initiative to Support Academic Research in Sweden   Chiesi Global Rare Disease is...
btnaree.png
1/29
Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges
2/29
Chiesi inleder fas III-studie för ny inhalator med minskat klimatavtryck
3/29
ARCHIVE NEWS AND PRESS RELEASE
April 2024
Chiesi fortsätter att vara en av Sveriges bästa arbetsplatser
btnboxnews.png
March 2024
Chiesi Group announces the passing of Honorary President Dr. Paolo Chiesi (1940-2024)
btnboxnews.png
Does COPD impact men and women equally?
btnboxnews.png
November 2023
TLV subventionerar Elfabrio för behandling av vuxna med Fabrys sjukdom
btnboxnews.png
Alexandra Argyriou och Mireia Cruz De los Santos får Cilla Weigelt-stipendium 2022 och 2023
btnboxnews.png
Chiesi Forges Strategic Partnership with SweDeliver: Advancing Drug Delivery Innovation
btnboxnews.png
October 2023
Chiesi and Karolinska Institutet (KI) Forge Strategic Research Alliance to Advance Precision...
btnboxnews.png
May 2023
TLV subventionerar Bronchitol vid cystisk fibros
btnboxnews.png
March 2023
Ny utbildning ska minska risken för feldiagnostisering och förbättra omhändertagandet av...
btnboxnews.png
November 2021
Webinar: Improving safety and efficacy of COPD treatment: towards addressing unmet needs
btnboxnews.png
Patientfall: okontrollerad astma hos vuxna
btnboxnews.png
Inhalerad Mannitol nu tillgängligt för patienter med Cystisk Fibros
btnboxnews.png
May 2021
Webinar inom ditt terapiområde
btnboxnews.png
Chiesi Group calls for #ActionOverWords in the fight against climate change
btnboxnews.png
February 2021
EU godkänner Trimbow – trippelkombination med extrafina partiklar för underhållsbehandling av...
btnboxnews.png
September 2020
Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for...
btnboxnews.png
Reducing the burden of asthma
btnboxnews.png
Asthma pharmacology
btnboxnews.png
June 2020
Chiesi Nordics supports employees, patients and caregivers during the Covid-19 pandemic
btnboxnews.png
April 2020
Cleaning your AeroChamber Flow-Vu
btnboxnews.png
March 2020
Chiesi Group increases support measures and announces new funds for employees, patients and...
btnboxnews.png
February 2020
Chiesi Group Announces Establishment of New Global Rare Diseases Division
btnboxnews.png
December 2019
Chiesi outlines €350 million investment and announces the development of the first carbon minimal...
btnboxnews.png
May 2019
Paolo Chiesi appointed Honorary Doctor at Karolinska Institutet
btnboxnews.png
February 2019
Chiesi Group receives the EURORDIS Black Pearl award for innovation in the field of Rare Disease.
btnboxnews.png
November 2018
World COPD Day - COPD, a disease still underestimated by Europeans: absence of perceived risk,...
btnboxnews.png
June 2018
Chiesi Group Integrates Zymenex into Chiesi Pharma AB and Strengthens its Presence in the Important...
btnboxnews.png
September 2016
The Lancet publishes the results of Chiesi Farmaceutici TRILOGY study
btnboxnews.png
February 2016
Chiesi is Top Employers again!
btnboxnews.png
November 2015
Alberto, Paolo and Andrea Chiesi winners of the “Entrepreneur of the year 2015” Award
btnboxnews.png
Special Mention to Holoclar at the Italian Galeno Award
btnboxnews.png
March 2014
COPD indication for Foster pMDI
btnboxnews.png
Double-digit growth and internal expansion for the Chiesi Group
btnboxnews.png
© 2024 Chiesi Pharma AB
Klara Norra kyrkogata 34, 111 22 Stockholm
Telefon +46 8 753 35 20
E-post infonordic@chiesi.com

R&D, Global Rare Diseases
Chiesi Pharma AB, Scheeles väg 2, 171 65 Solna
Telefon + 46 8 753 35 20
Updated at 02/10/2017
CHIESI ON THE WEB
mappa.png